Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease.
14-3-3 protein
Cytokines
Inflammation
Inflammatory bowel disease
Phosphorylation
Tristetraprolin
Journal
World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448
Informations de publication
Date de publication:
21 Oct 2019
21 Oct 2019
Historique:
received:
01
08
2019
revised:
06
09
2019
accepted:
27
09
2019
entrez:
30
10
2019
pubmed:
30
10
2019
medline:
27
2
2020
Statut:
ppublish
Résumé
Intestinal inflammation and epithelial injury are the leading actors of inflammatory bowel disease (IBD), causing an excessive pro-inflammatory cytokines expression. Tristetraprolin (TTP), an mRNA binding protein, plays a role in regulating the inflammatory factors, recognizing specific sequences on the 3' untranslated region of cytokine mRNAs. TTP activity depends on its phosphorylation state: the unphosphorylated TTP degrades pro-inflammatory cytokine mRNAs; on the contrary, the phosphorylated TTP fails to destabilize mRNAs furthering their expression. The phospho-TTP forms a complex with the chaperone protein 14-3-3. This binding could be one of the factors that promote intestinal inflammation as a cause of disease progression. To assess if TTP phosphorylation has a role in paediatric IBD. The study was carried out on a cohort of paediatric IBD patients. For each patient enrolled, a specimen of inflamed and non-inflamed colonic mucosa was collected. Furthermore, the experiments were conducted on macrophages differentiated from blood samples of the same patients. Macrophages from healthy donors' blood were used as controls. Co-immunoprecipitation assay and immunoblotting analyses were performed to observe the formation of the phospho-TTP/14-3-3 complex. In the same samples TNF-α expression was also evaluated as major factor of the pro-inflammatory activity. In this work we studied indirectly the phosphorylation of TTP through the binding with the chaperone protein 14-3-3. In inflamed and non-inflamed colon mucosa of IBD paediatric patients immunoblot assay demonstrated a higher expression of the TTP in inflamed samples respect to the non-inflamed; the co-immunoprecipitated 14-3-3 protein showed the same trend of expression. In the In this work, for the first time, we describe a relation between phospho-TTP/14-3-3 complex and IBD. Indeed, a higher expression of TTP/14-3-3 was recorded in IBD samples in comparison to controls.
Sections du résumé
BACKGROUND
BACKGROUND
Intestinal inflammation and epithelial injury are the leading actors of inflammatory bowel disease (IBD), causing an excessive pro-inflammatory cytokines expression. Tristetraprolin (TTP), an mRNA binding protein, plays a role in regulating the inflammatory factors, recognizing specific sequences on the 3' untranslated region of cytokine mRNAs. TTP activity depends on its phosphorylation state: the unphosphorylated TTP degrades pro-inflammatory cytokine mRNAs; on the contrary, the phosphorylated TTP fails to destabilize mRNAs furthering their expression. The phospho-TTP forms a complex with the chaperone protein 14-3-3. This binding could be one of the factors that promote intestinal inflammation as a cause of disease progression.
AIM
OBJECTIVE
To assess if TTP phosphorylation has a role in paediatric IBD.
METHODS
METHODS
The study was carried out on a cohort of paediatric IBD patients. For each patient enrolled, a specimen of inflamed and non-inflamed colonic mucosa was collected. Furthermore, the experiments were conducted on macrophages differentiated from blood samples of the same patients. Macrophages from healthy donors' blood were used as controls. Co-immunoprecipitation assay and immunoblotting analyses were performed to observe the formation of the phospho-TTP/14-3-3 complex. In the same samples TNF-α expression was also evaluated as major factor of the pro-inflammatory activity.
RESULTS
RESULTS
In this work we studied indirectly the phosphorylation of TTP through the binding with the chaperone protein 14-3-3. In inflamed and non-inflamed colon mucosa of IBD paediatric patients immunoblot assay demonstrated a higher expression of the TTP in inflamed samples respect to the non-inflamed; the co-immunoprecipitated 14-3-3 protein showed the same trend of expression. In the
CONCLUSION
CONCLUSIONS
In this work, for the first time, we describe a relation between phospho-TTP/14-3-3 complex and IBD. Indeed, a higher expression of TTP/14-3-3 was recorded in IBD samples in comparison to controls.
Identifiants
pubmed: 31660029
doi: 10.3748/wjg.v25.i39.5918
pmc: PMC6815796
doi:
Substances chimiques
14-3-3 Proteins
0
Tristetraprolin
0
ZFP36 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5918-5925Informations de copyright
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare no competing financial, personal or professional conflicts of interest.
Références
Int J Mol Med. 2006 Aug;18(2):273-8
pubmed: 16820934
J Biol Chem. 2010 Sep 3;285(36):27590-600
pubmed: 20595389
Nucleic Acids Res. 1991 Jun 25;19(12):3454
pubmed: 2062660
Mol Cell Biol. 2006 Mar;26(6):2408-18
pubmed: 16508015
Mol Cell Biol. 2001 Oct;21(19):6461-9
pubmed: 11533235
Mol Biosyst. 2012 Jan;8(1):178-84
pubmed: 21947246
Nat Rev Immunol. 2014 May;14(5):329-42
pubmed: 24751956
Science. 1998 Aug 14;281(5379):1001-5
pubmed: 9703499
EMBO J. 2004 Mar 24;23(6):1313-24
pubmed: 15014438
Int J Biochem Cell Biol. 2018 Jan;94:6-9
pubmed: 29128684
Ann Rheum Dis. 2017 Mar;76(3):612-619
pubmed: 27597652
Immunity. 1996 May;4(5):445-54
pubmed: 8630730
BMJ. 2017 May 31;357:j2083
pubmed: 28566467
J Immunol. 2015 Jul 1;195(1):265-76
pubmed: 26002976
Biochim Biophys Acta. 2013 Jun-Jul;1829(6-7):666-79
pubmed: 23428348
Genes Dev. 2005 Feb 1;19(3):351-61
pubmed: 15687258
Inflamm Bowel Dis. 2011 Jan;17(1):471-8
pubmed: 20725943
Mol Endocrinol. 1996 Feb;10(2):140-6
pubmed: 8825554
JAMA Pediatr. 2015 Nov;169(11):1053-60
pubmed: 26414706
Gene. 2001 Mar 7;265(1-2):11-23
pubmed: 11255003
Biochem Soc Trans. 2016 Oct 15;44(5):1321-1337
pubmed: 27911715